S

    Solventum Corp. (SOLV)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE

    $91.13
    +0.01 (+0.01%)

    Market Cap: $15.51B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    90%(9/10)
    Avg Surprise
    +11.32%
    Streak
    6 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$1.35
    Range$1.29 - $1.43
    11 analysts
    EPS Revisions
    1
    0
    7d
    2
    8
    30d
    EPS Estimate Drift
    90d ago$1.43+5.7%
    60d ago$1.43+5.4%
    30d ago$1.41+4.3%
    7d ago$1.35-0.2%
    Current$1.35
    Revenue Consensus
    $1.9B
    Range$1.9B - $2.0B
    11 analysts
    Dec 31, 2026
    EPS Consensus$2.57
    Range$2.51 - $2.94
    14 analysts
    Revenue Consensus
    $2.2B
    Range$2.0B - $2.2B
    13 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$2.57---
    Sep 26EST
    		-$1.35---
    Jun 26
    		$2.55$1.91+33.51%Beat+50.9%
    Mar 26
    		$1.48$1.35+9.63%Beat+10.4%
    Dec 25
    		$1.57$1.50+4.67%Beat+11.3%
    Sep 25
    		$1.50$1.43+4.90%Beat-8.5%
    Jun 25
    		$1.69$1.45+16.55%Beat+8.3%
    Mar 25
    		$1.34$1.22+9.84%Beat-35.6%
    Dec 24
    		$1.41$1.50-6.00%Miss-39.0%
    Sep 24
    		$1.64$1.39+17.99%Beat-
    Jun 24
    		$1.56$1.51+3.31%Beat-
    Mar 24
    		$2.08$1.75+18.86%Beat-
    Dec 23
    		$2.31$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio12.84EV/EBITDA8.26x
    Price/FCF-133.37xFCF Yield-0.75%
    Profitability
    Profit Margin17.30%Operating Margin9.78%
    ROE34.00%ROIC17.51%
    Financial Health
    Debt/Equity1.06xInterest Coverage7.12x
    Current Ratio1.02xQuick Ratio0.74x
    Trading Statistics
    Beta0.67Avg Volume1.17M
    52-Week High$92.7152-Week Low$62.38

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$90.10
    SMA 20$87.94
    SMA 50$82.70
    SMA 200$77.06
    EMA 10$90.05
    EMA 20$88.20
    EMA 50$84.03
    EMA 200$77.80

    MACD

    Line: 2.47Signal: 2.38Hist: 0.09

    ADX

    ADX: 24.4+DI: 28.3-DI: 18.3

    Aroon & PSAR

    Aroon Up88.0
    Aroon DownN/A
    PSAR$88.24

    Bollinger Bands

    Upper Band$93.61
    Lower Band$82.27
    %B Position1289%(Upper)
    Band Width0.78

    RSI (14-Day)

    Neutral
    65.2

    Momentum Oscillators

    Stoch %K84.5
    Stoch %D86.8
    Williams %R-15.1
    ROC (10d)5.0%
    Momentum4.31
    CCI (20d)96.1
    MFI (14d)67.0

    Volatility Measures

    ATR (14d)$2.31(2.5%)
    StdDev (20d)2.83
    Hist Vol27.2%(Moderate)

    Volume Flow

    VWAP$91.02
    OBV-802.1K
    AD Line1.8M
    CMF (20d)0.092

    Volume Metrics

    Avg Vol (20d)1.2M
    Vol Ratio0.8x
    VWMA (20d)$87.52

    Pivot Points

    R3$92.66
    R2$92.18
    R1$91.65
    Pivot Point$91.17
    S1$90.64
    S2$90.16
    S3$89.63

    Advanced Oscillators

    TSI27.17
    Ultimate Osc62.7
    KST98.16

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$2.21B$2.01B$2.00B$2.10B$2.16B$2.07B$2.08B$2.08B$2.08B$2.02B$2.04B$2.07B
    Cost of Revenue$923.00M$911.00M$971.00M$961.00M$986.00M$956.00M$956.00M$917.00M$944.00M$844.00M$878.00M$865.00M
    Gross Profit$1.29B$1.10B$1.03B$1.14B$1.18B$1.11B$1.12B$1.17B$1.14B$1.17B$1.16B$1.21B
    Operating Expenses$1.10B$1.02B$902.00M$-555,000,000$961.00M$962.00M$983.00M$890.00M$893.00M$791.00M$752.00M$705.00M
    R&D$178.00M$189.00M$174.00M$183.00M$189.00M$193.00M$199.00M$189.00M$192.00M$195.00M$190.00M$180.00M
    SG&A$927.00M$827.00M$759.00M$780.00M$772.00M$769.00M$784.00M$701.00M$701.00M$596.00M$618.00M$525.00M
    Operating Income$181.00M$81.00M$125.00M$1.69B$214.00M$152.00M$136.00M$275.00M$244.00M$381.00M$406.00M$504.00M
    Interest Income$-64,000,000$-62,000,000$-51,000,000$-89,000,000$-103,000,000$-104,000,000$-107,000,000$-107,000,000$-114,000,000$-39,000,000$0$0
    Interest Expense$73.00M$65.00M$67.00M$82.00M$111.00M$114.00M$123.00M$0$148.00M$52.00M$15.00M$4.00M
    Income Before Tax$108.00M$16.00M$58.00M$1.51B$103.00M$38.00M$13.00M$167.00M$96.00M$329.00M$391.00M$500.00M
    Income Tax Expense$15.00M$3.00M$-5,000,000$248.00M$13.00M$-99,000,000$-17,000,000$45.00M$7.00M$92.00M$119.00M$40.00M
    Net Income$92.00M$13.00M$63.00M$1.27B$90.00M$137.00M$31.00M$122.00M$89.00M$237.00M$272.00M$460.00M
    EBITDA$305.00M$212.00M$227.00M$1.81B$328.00M$270.00M$270.00M$407.00M$343.00M$507.00M$530.00M$644.00M
    EBIT$172.00M$77.00M$110.00M$1.69B$206.00M$141.00M$120.00M$274.00M$210.00M$368.00M$391.00M$500.00M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SOLV

    News

    Biotech Stocks At 52-Week Highs - VOGX, PHVS, SOLV, IKT, HTFL

    Several biotech stocks, including Vogenx Inc. (VOGX), Pharvaris N.V. (PHVS), Solventum Corporation (SOLV), Inhibikase Therapeutics Inc. (IKT), and HeartFlow Inc. (HTFL), reached 52-week highs on August 24, 2026. These gains were primarily driven by positive clinical trial results, upcoming conference participation, or strong financial performance and strategic realignments. The article details the specific advancements and financial updates for each company contributing to their stock performance.

    RTTNews•8/25/26•
    Bullish

    Solventum Corp. stock rises Monday, outperforms market

    Solventum Corp. (SOLV) stock increased by 1.88% to $91.25 on Monday, outperforming the broader market during a mixed trading session. The Dow Jones Industrial Average rose, while the S&P 500 Index declined. This marks the fifth consecutive day of gains for Solventum Corp. stock.

    MarketWatch•8/24/26•
    Bullish

    Solventum Corp stock hits 52-week high at 90.05 USD

    Solventum Corp's stock has reached a new 52-week high at $90.05, reflecting strong investor confidence and a 23.12% increase over the past year. The company's recent second-quarter earnings surpassed Wall Street expectations, driven by strong organic growth and a tariff refund, leading to an adjusted earnings of $2.55 per share against a forecast of $1.51. Solventum has also raised its future outlook, indicating confidence in continued growth.

    Investing.com•8/24/26•
    Bullish

    Solventum Corp stock hits 52-week high at 90.05 USD

    Solventum Corp's stock has reached a 52-week high of $90.05, driven by strong investor confidence and positive market performance, including a 23.12% increase over the past year. The company recently reported second-quarter earnings that surpassed Wall Street expectations, with adjusted earnings of $2.55 per share and revenue of $2.2 billion, leading to a raised outlook for future growth. InvestingPro analysis suggests the stock is fairly valued with a market capitalization of $15.25 billion and a P/E ratio of 9.3.

    Investing.com India•8/24/26•
    Bullish

    Why Did Align Technology (ALGN) Move Today?

    Align Technology (ALGN) has seen recent share price movements, closing at $162.55, with a 1-day gain of 2.27% but a 7-day decline of 10.35%. Despite recent volatility, the company is considered 22.3% undervalued by analysts, with a fair value estimate of $209.07, driven by the expansion of Invisalign indications and increased adoption by dentists. However, key risks include competition from lower-priced clear aligner products and an ongoing EU antitrust investigation.

    Simply Wall Street•8/23/26•
    Neutral

    Frequently Asked Questions About SOLV

    Does SOLV pay dividends?
    Solventum Corp. (SOLV) does not currently pay a regular dividend.
    What is SOLV's P/E ratio?
    Solventum Corp. has a price-to-earnings (P/E) ratio of 12.84.
    What is SOLV's market cap?
    Solventum Corp. (SOLV) has a market capitalization of $15.51B with a current stock price of $91.13.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In